Overview

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study

Status:
Completed

Trial end date:
2014-01-22

Target enrollment:

Participant gender:

Summary

This will be an open-label, three-period, fixed-sequence study to evaluate the drug-drug interaction, pharmacokinetics and safety of dutasteride and tamsulosin when administered alone and in-combination in Chinese healthy male volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Dutasteride
Tamsulosin